The U.S. Food and Drug Administration has just approved a new pediatric vaccine that will immunize children between the ages of six weeks and four years from six different diseases including diphtheria, tetanus, pertussis, poliomyelitis, hepatitis B, and invasive disease resulting from haemophilus influenzae type B.
Approved to be labeled as Vaxelis because the first letter of the six diseases it protects from would be impossible to say, this new children’s vaccine was developed by Sanofi during a partnership with Merck.
“Under this license, you are authorized to manufacture the product,” the official approval letter from the FDA dated December 21st reads.
Sanofi and Merck are currently working to make the new pediatric vaccine available in the next two or so years.
According to the Centers for Disease Control and Prevention, there are currently 14 preventable diseases parents are urged to immunize their children against. This new vaccine will provide children with immunity from six of them.
0 comments :
Post a Comment